Eurazeo - Asset Resilience Ratio
Eurazeo (RF) has an Asset Resilience Ratio of 0.08% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See RF working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2025)
This chart shows how Eurazeo's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see balance sheet size of Eurazeo.
Liquid Assets Composition Over Time
This chart breaks down Eurazeo's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore investment intensity of Eurazeo to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €6.88 Million | 0.08% |
| Total Liquid Assets | €6.88 Million | 0.08% |
Asset Resilience Insights
- Limited Liquidity: Eurazeo maintains only 0.08% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Eurazeo Industry Peers by Asset Resilience Ratio
Compare Eurazeo's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Bajaj Holdings & Investment Limited
NSE:BAJAJHLDNG |
Asset Management | 1.12% |
|
Nippon Life India Asset Management Limited
NSE:NAM-INDIA |
Asset Management | 5.50% |
|
KBC Ancora
BR:KBCA |
Asset Management | 1.63% |
|
Sofina Société Anonyme
BR:SOF |
Asset Management | 4.11% |
|
WisdomTree Inc.
NYSE:WT |
Asset Management | 2.29% |
|
Sprott Inc.
TO:SII |
Asset Management | 1.84% |
|
MFF Capital Investments Ltd
AU:MFF |
Asset Management | 93.74% |
|
BlackRock Science and Technology Trust II
NYSE:BSTZ |
Asset Management | 1.69% |
Annual Asset Resilience Ratio for Eurazeo (2011–2025)
The table below shows the annual Asset Resilience Ratio data for Eurazeo.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.06% | €5.03 Million ≈ $5.88 Million |
€8.19 Billion ≈ $9.57 Billion |
-0.29pp |
| 2024-12-31 | 0.35% | €33.38 Million ≈ $39.03 Million |
€9.42 Billion ≈ $11.01 Billion |
+0.00pp |
| 2023-12-31 | 0.35% | €34.54 Million ≈ $40.38 Million |
€9.77 Billion ≈ $11.42 Billion |
+0.15pp |
| 2022-12-31 | 0.21% | €38.83 Million ≈ $45.39 Million |
€18.86 Billion ≈ $22.04 Billion |
-2.36pp |
| 2021-12-31 | 2.57% | €418.49 Million ≈ $489.26 Million |
€16.30 Billion ≈ $19.05 Billion |
+1.52pp |
| 2020-12-31 | 1.05% | €144.63 Million ≈ $169.09 Million |
€13.83 Billion ≈ $16.17 Billion |
+0.75pp |
| 2019-12-31 | 0.30% | €41.56 Million ≈ $48.58 Million |
€13.91 Billion ≈ $16.26 Billion |
-0.03pp |
| 2018-12-31 | 0.32% | €39.28 Million ≈ $45.93 Million |
€12.12 Billion ≈ $14.17 Billion |
+0.00pp |
| 2017-12-31 | 0.32% | €37.45 Million ≈ $43.78 Million |
€11.57 Billion ≈ $13.52 Billion |
-0.74pp |
| 2016-12-31 | 1.06% | €110.33 Million ≈ $128.99 Million |
€10.38 Billion ≈ $12.14 Billion |
-0.35pp |
| 2015-12-31 | 1.41% | €104.19 Million ≈ $121.81 Million |
€7.38 Billion ≈ $8.62 Billion |
+0.36pp |
| 2014-12-31 | 1.06% | €130.06 Million ≈ $152.05 Million |
€12.31 Billion ≈ $14.39 Billion |
+0.25pp |
| 2013-12-31 | 0.81% | €98.93 Million ≈ $115.66 Million |
€12.27 Billion ≈ $14.35 Billion |
+0.24pp |
| 2012-12-31 | 0.57% | €76.40 Million ≈ $89.32 Million |
€13.51 Billion ≈ $15.79 Billion |
+0.06pp |
| 2011-12-31 | 0.51% | €73.50 Million ≈ $85.93 Million |
€14.54 Billion ≈ $17.00 Billion |
-- |
About Eurazeo
Eurazeo SE is a private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, … Read more